Beitelshees AL - Search Results

1

Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.

Beitelshees AL, Zineh I. Beitelshees AL, et al. Heart Fail Rev. 2010 May;15(3):209-17. doi: 10.1007/s10741-008-9092-z. Epub 2008 Mar 20. Heart Fail Rev. 2010. PMID: 18351457 Free PMC article. Review.

2

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.

Zineh I, Gerhard T, Aquilante CL, Beitelshees AL, Beasley BN, Hartzema AG. Zineh I, et al. Among authors: beitelshees al. Pharmacogenomics J. 2004;4(6):354-8. doi: 10.1038/sj.tpj.6500284. Pharmacogenomics J. 2004. PMID: 15483659 No abstract available.

3

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.

Zineh I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K, Leeder JS, Phillips MS, Gelfand CA, Johnson JA. Zineh I, et al. Among authors: beitelshees al. Clin Pharmacol Ther. 2004 Dec;76(6):536-44. doi: 10.1016/j.clpt.2004.08.020. Clin Pharmacol Ther. 2004. PMID: 15592325

4

Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.

Beitelshees AL, Zineh I, Yarandi HN, Pauly DF, Johnson JA. Beitelshees AL, et al. Pharmacogenomics J. 2006 May-Jun;6(3):174-8. doi: 10.1038/sj.tpj.6500354. Pharmacogenomics J. 2006. PMID: 16402084

5

CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).

Zineh I, Aquilante CL, Langaee TY, Beitelshees AL, Arant CB, Wessel TR, Schofield RS. Zineh I, et al. Among authors: beitelshees al. Cytokine. 2006 Mar 7;33(5):258-63. doi: 10.1016/j.cyto.2006.02.008. Epub 2006 Mar 29. Cytokine. 2006. PMID: 16567110

6

Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs.

Zineh I, Pebanco GD, Aquilante CL, Gerhard T, Beitelshees AL, Beasley BN, Hartzema AG. Zineh I, et al. Among authors: beitelshees al. Ann Pharmacother. 2006 Apr;40(4):639-44. doi: 10.1345/aph.1G464. Epub 2006 Mar 7. Ann Pharmacother. 2006. PMID: 16595569

7

Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.

Beitelshees AL, Zineh I, Yarandi HN, Pauly DF, Johnson JA. Beitelshees AL, et al. Pharmacotherapy. 2006 Sep;26(9):1247-54. doi: 10.1592/phco.26.9.1247. Pharmacotherapy. 2006. PMID: 16945046 Clinical Trial.

8

Common laboratory methods in pharmacogenomics studies.

Aquilante CL, Zineh I, Beitelshees AL, Langaee TY. Aquilante CL, et al. Among authors: beitelshees al. Am J Health Syst Pharm. 2006 Nov 1;63(21):2101-10. doi: 10.2146/ajhp060068. Am J Health Syst Pharm. 2006. PMID: 17057047

9

Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease.

Aquilante CL, Beitelshees AL, Zineh I. Aquilante CL, et al. Among authors: beitelshees al. Clin Chim Acta. 2007 Apr;379(1-2):48-52. doi: 10.1016/j.cca.2006.12.006. Epub 2006 Dec 20. Clin Chim Acta. 2007. PMID: 17254561

10

NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes.

Zineh I, Beitelshees AL, Haller MJ. Zineh I, et al. Among authors: beitelshees al. Diabetes Care. 2007 Mar;30(3):689-93. doi: 10.2337/dc06-1697. Diabetes Care. 2007. PMID: 17327342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters